Metraipolis › archive › dc_ed846bbec6f2

Developing Highly Effective Nanoparticle mRNA Therapeutic for Pediatric Acute Respiratory Distress Syndrome — Europe PMC PMID:42752987

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42752987
DOI
10.1002/advs.77813
License (as archived)
solo-consultazione
Archived
2026-10-08T11:23:58.393Z
SHA-256 of the archived text
128f012bfeebdbfbe4365bd2703bbcb654e4995d00d685900ad9a2b4e7f929a9
Stable URL of this page
https://metraipolis.com/documento/dc_ed846bbec6f2

How to cite

Developing Highly Effective Nanoparticle mRNA Therapeutic for Pediatric Acute Respiratory Distress Syndrome — Europe PMC PMID:42752987 — Europe PMC (en), https://europepmc.org/article/MED/42752987 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ed846bbec6f2 (Metraipolis archive dc_ed846bbec6f2, sha256 128f012bfeebdbfbe4365bd2703bbcb654e4995d00d685900ad9a2b4e7f929a9)
BibTeX
@misc{dced846bbec6f2,
  title = {Developing Highly Effective Nanoparticle mRNA Therapeutic for Pediatric Acute Respiratory Distress Syndrome — Europe PMC PMID:42752987},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42752987},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ed846bbec6f2; sha256 128f012bfeebdbfbe4365bd2703bbcb654e4995d00d685900ad9a2b4e7f929a9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42752987. Agents can read the archived copy with the MCP tool read_document.